首页> 外国专利> Pharmaceutical composition comprising N - 4 - (5H - 2.1 - pyrrole c 1,4 benzodiazepines - 10 - (11h) ilcarbonil 3-chlorophenyl - 5-fluoro-2 - methylbenzamide, a Surfactant, Polyethylene glycols,Sucrose Esters of fatty acid and / or polyvinylpyrrolidone, preparing procedure, useful as a diuretic.

Pharmaceutical composition comprising N - 4 - (5H - 2.1 - pyrrole c 1,4 benzodiazepines - 10 - (11h) ilcarbonil 3-chlorophenyl - 5-fluoro-2 - methylbenzamide, a Surfactant, Polyethylene glycols,Sucrose Esters of fatty acid and / or polyvinylpyrrolidone, preparing procedure, useful as a diuretic.

机译:包含N- [4-(5H-2.1-吡咯[c] [1,4]苯并二氮杂卓-10-(11h)伊卡替尔3-氯苯基] -5-氟-2-甲基苯甲酰胺,表面活性剂,聚乙二醇,蔗糖的药物组合物脂肪酸和/或聚乙烯吡咯烷酮的酯,制备方法,可用作利尿剂。

摘要

The present Invention provides novel formulations of N - (4 - (5h pyrrolo (2.1) (1,4) - 10 benzodiazepines (11h) ilcarbonil) - (3-chlorophenyl) - 5-fluoro-2 - methylbenzamide,Or a pharmaceutically acceptable Salt thereof, and a process for their preparation, their formulations comprise from about 1% to about 20% of active ingredientsFrom about 1% to around 18% of a Surfactant Component, from about 50% to about 80% of a component of one or more Polietilen glycolsFrom about 1% to about 20% of a component made of one or more Fatty Acid Esters of sucrose and / or polyvinylpyrrolidone and optionally one or more preservatives and antioxidantIs pharmaceutically acceptable.
机译:本发明提供了N-(4-(5h吡咯并(2.1)(1,4)-10苯二氮卓类(11h)ilcarbil)-(3-氯苯基)-5-氟-2-甲基苯甲酰胺的新制剂,或药学上可接受的制剂其盐及其制备方法,其制剂包含约1%至约20%的活性成分,约1%至约18%的表面活性剂成分,约50%至约80%的一种或多种成分。由一种或多种蔗糖和/或聚乙烯吡咯烷酮的脂肪酸酯以及任选地一种或多种防腐剂和抗氧化剂制成的组分的约1%至约20%是药学上可接受的。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号